Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Australia ETF (EWA) vs Novo Nordisk A/S (NVO) Price & Performance

iShares MSCI Australia ETFTrade
Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

iShares MSCI Australia ETF vs Novo Nordisk A/S — how do they compare? iShares MSCI Australia ETF trades at $30.23, while Novo Nordisk A/S trades at $45.99 (market cap $207.85B). The key difference: Novo Nordisk A/S pays a 3.81% dividend while iShares MSCI Australia ETF pays none, and iShares MSCI Australia ETF is trading nearer its 52-week high, Novo Nordisk A/S nearer its low. Which is the better fit depends on your goals.

EWANVO
Sector
Broad Market / FactorHealth
52-Week High
$30.41$63.98
52-Week Low
$24.95$35.29
Market Cap
$207.85B
Enterprise Value
$222.55B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

About iShares MSCI Australia ETF

EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.

Read more on EWA

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO